A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/405 (2006.01) A61K 31/495 (2006.01) A61K 31/50 (2006.01)
Patent
CA 2527284
The present invention relates to cortisol-modulating compounds, inlcluding but not limited to benzamide and benzoic acid derivatives such as procaine and procaine derivatives, utilized in compositions and methods for treating cortisol-mediated disorders, including but not limited to age-related depression, hypertension, Alzheimer's disease, and acquired immunodeficiency syndrome.
L'invention concerne des composés modulant le cortisol, notamment des dérivés de benzamide et d'acide benzoïque, tels que la procaïne et des dérivés de la procaïne. Les composés selon l'invention sont utilisés dans des compositions et des méthodes qui permettent de traiter les troubles médiés par le cortisol, notamment la dépression liée à l'âge, l'hypertension, la maladie d'Alzheimer et le syndrome d'immunodéficience acquise.
Greeson Janet
Lecanu Laurent
Papadopoulos Vassilios
Xu Jing
Georgetown University
Samaritan Pharmaceuticals Inc.
Sim & Mcburney
LandOfFree
Methods and compositions for modulating serum cortisol levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for modulating serum cortisol levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating serum cortisol levels will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2027006